FDA Willing to Authorize Coronavirus Vaccine Before Phase 3 Trials Are Complete, Agency Head Says
However, the ultimate decision will be based on the data the companies submit, he notes.
Full Article
FDA Willing to Authorize Coronavirus Vaccine Before Phase 3 Trials Are Complete, Agency Head Says
Motley Fool
0 shares
1 views
You might like
Related news coverage
FDA Will Consider OK'ing COVID-19 Vaccine Before End Of Phase 3 Trials
Newsy
Watch VideoThe head of the Food and Drug Administration says he’d consider bypassing the usual approval process to get a..
-
NA Proactive news snapshot: Aequus Pharmaceuticals, Acasti Pharma, Internet of Things, Revive Therapeutics UPDATE ....
Proactive Investors
-
FDA May Authorize Vaccine Before Trials Finish
Newsy
-
U.S. FDA chief willing to approve a COVID-19 vaccine before Phase 3 trials end
National Post
-
FDA commissioner says willing to fast-track COVID-19 vaccine - FT
Jerusalem Post
Advertisement
More coverage
Antibe Therapeutics plans to file IND with regulator for lead drug otenaproxesul
Proactive Investors
Antibe Therapeutics Inc (CVE:ATE) (OTCQB:ATBPF) has revealed that it plans to file an Investigational New Drug (IND) application..